1. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929-38. [
DOI:10.1016/S0140-6736(07)61696-1]
2. Choi H, Lee M, Chen RY, Kim Y, Yoon S, Joh JS, et al. Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012. BMC Infectious Diseases. 2014;14(1):360. [
DOI:10.1186/1471-2334-14-360] [
PMID] [
PMCID]
3. CHang KC, YEW WW. Management of difficult multidrug‐resistant tuberculosis and extensively drug‐resistant tuberculosis: update 2012. Respirology. 2013;18(1):8-21. [
DOI:10.1111/j.1440-1843.2012.02257.x] [
PMID]
4. Hatami H, Razavi S, Eftekhar H, Majlesi F. Comprehensive book of public health. Tehran: Arjemand Publications. 2007:45-7.
5. Organization WH. Global tuberculosis report 2013: World Health Organization; 2013. Book
6. Soria J, Metcalf T, Mori N, Newby RE, Montano SM, Huaroto L, et al. Mortality in hospitalized patients with tuberculous meningitis. BMC Infectious Diseases. 2019;19(1):9. [
DOI:10.1186/s12879-018-3633-4] [
PMID] [
PMCID]
7. Hassan Zadeh J, Nasehi M, Rezaianzadeh A, Tabatabaee H, Rajaeifard A, Ghaderi E. Pattern of reported tuberculosis cases in iran 2009-2010. Iranian journal of public health. 2013;42(1):72-8.
8. Organization WH. Global tuberculosis control: epidemiology, strategy, financing: WHO report 2009: World Health Organization; 2009. Book
9. Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. The New England journal of medicine. 1989; 320(9):545-50. [
DOI:10.1056/NEJM198903023200901] [
PMID]
10. Shamu S, Kuwanda L, Farirai T, Guloba G, Slabbert J, Nkhwashu N. Study on knowledge about associated factors of Tuberculosis (TB) and TB/HIV co-infection among young adults in two districts of South Africa. PloS one. 2019;14(6):e0217836. 10.1371/journal.pone.0217836. [
DOI:10.1371/journal.pone.0217836] [
PMID] [
PMCID]
11. MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global Epidemiology of Tuberculosis and Progress Toward Achieving Global Targets - 2017. MMWR Morb Mortal Wkly Rep. 2019;68(11):263-6. [
DOI:10.15585/mmwr.mm6811a3] [
PMID] [
PMCID]
12. Yazdani-Chrati J, Mrdanshah F, Etemadi-Nejad S, Rezaei M-S, Ghadami M, Ahmadi-Baseri E. Application of empirical Bayes smoothed incidence rates of tuberculosis during the year 2005-2011 to prepare geographical map of tuberculosis incidence. Journal of Mazandaran University of Medical Sciences. 2014;23(110):45-56.
13. Ebrahimzadeh A, Sharifzadeh GR, Eshaghi S. The epidemiology of Tuberculosis in Birjand (1996-2006). Journal of Birjand University of Medical Sciences. 2009;16(1):31-8.
14. Najafzadeh H, Ghorbani K. Epidemiology of tuberculosis in a health center in Rasht city in 86 years. 5th National Congress of Tuberculosis 2009.
15. Organization WH. Global Tuberculosis Report. Geneva: World Health Organization; 2014. 2016.
16. Martinez AN, Rhee JT, Small PM, Behr MA. Sex differences in the epidemiology of tuberculosis in San Francisco. International Journal of Tuberculosis and Lung Disease. 2000;4(1):26-31.
17. Amani F, Bashiri J, Sabzevari A, Gharoosi B, Nahanmoghaddam N. Epidemiology of Tuberculosis in Ardabil, 2001-2005. Journal of Ardabil University of Medical Sciences. 2007;7(3):236-341.
18. Yazdani Charati J, Kazemnejad A, Mosazadeh M. An epidemiological study on the reported cases of tuberculosis in Mazandaran (1999-2008) using spatial design. Journal of Mazandaran University of Medical Sciences. 2010;19(74):9-16.
19. Nili S, Karimi M, Banafshi O. Epidemiologic study of extrapulmonary TB in kurdistan 2007-2009. 19 th Iranian congress on infectious diseases and tropical medicine 2010; Iran2010. p. 138.
20. Mohamadi Azni S, Mansourian AA, Nokandeh Z. Epidemiological study of tuberculosis in Damghan city (Iran) during 2003-2007. koomesh. 2008;9(4):315-20.
21. Abbasi A, Arabi M. Efficiency of Dots strategy in Recovery or reverse of tuberculosis Patient. Journal of Gorgan Medical Science university. 2004;6(13):78-84.
22. Najafzadeh H, Ghorbani K, Sedighi A, Asadi S, Rezaee A. Epidemiologic study of tuberculosis in a health center in Rasht city in 2007. 19th National Congress of tuberculosis; Zanjan, Iran2008. p. 20.
23. Tavakoli A. Incidence and Prevalence of Tuberculosis in Iran and Neighboring Countries. Zahedan Journal of Research in Medical Sciences 2017;19(7):e9238. [
DOI:10.5812/zjrms.9238]
24. Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, Venkatesan P. Socio-economic impact of tuberculosis on patients and family in India. The international journal of tuberculosis and lung disease. 1999;3(10):869-77.
25. Hazrati S, Khaligh N, Moeini A, Amani F, Barak M, Rahimi G, et al. Epidemiology of Tuberculosis in Ardabil City from 2005 to 2010. Journal of Health. 2013;4(2):103-9.
26. WHO. World Health organization global tuberculosis: Tuberculosis 2018 [Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis.
27. Rajagopalan S, Yoshikawa TT. Tuberculosis in the elderly. Zeitschrift fur Gerontologie und Geriatrie. 2000;33(5):374-80. [
DOI:10.1007/s003910070034] [
PMID]
28. Caylà JA, Orcau A. Control of tuberculosis in large cities in developed countries: an organizational problem. BMC Medicine. 2011;9(1):127. [
DOI:10.1186/1741-7015-9-127] [
PMID] [
PMCID]
29. Owiti P, Onyango D, Momanyi R, Harries AD. Screening and testing for tuberculosis among the HIV-infected: outcomes from a large HIV program in western Kenya. BMC Public Health. 2019;19(1):29-. [
DOI:10.1186/s12889-018-6334-4] [
PMID] [
PMCID]